Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 Q2- Text added to 2018 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
Coll. sophomore Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
Coll freshman Bad
|
New words:
administered, affiliate, alternate, announced, arm, back, BIDMC, biochemically, biological, biopsy, booster, bringing, Collin, concentration, Contract, conventional, County, demonstrated, detailing, digital, disease, doctor, dose, doubling, drastic, efficacy, enroll, Enrollment, entry, FDA, fight, Financingin, Fort, Frame, frequently, goal, hospital, hosted, impotence, incontinence, induction, injection, intervention, intradermally, IRB, listing, live, low, Marketplace, mentioned, monitor, North, OTC, past, Pink, post, preeminent, Primary, progressing, progression, protocol, proxy, PSA, publicly, Puritan, radiotherapy, rectal, recurrent, resume, Rockwall, safety, Secondary, side, stable, surgery, surveillance, survival, Tarrant, teaching, tentatively, test, Theradex, therapy, University, unpleasant, urinary, urology, week, Worth
Valuein 2018 Q2 filing- Value in 2018 Q3 filing
Original filings
Filing view